Synthetic coating for cell culture

ABSTRACT

A method for coating a surface of a cell culture article includes dissolving a polymer having a covalently attached polypeptide in an aqueous solution to produce a polymer solution. The polymer is formed from monomers selected to form a polymer having a linear backbone, wherein the polymer is crosslink free. The weight percentage of the polypeptide relative to the polymer conjugated to the polypeptide is sufficiently high to render the polymer conjugated to the polypeptide water soluble. The aqueous solution is substantially free of organic solvents. The method further includes (i) disposing the polymer solution on the surface of the cell culture article to produce a coated article; and (ii) subjecting the coated article to sufficient heat or electromagnetic radiation to attach the polymer conjugated to a polypeptide to the surface of the cell culture article.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No.14/970,618 filed on Dec. 16, 2015, which is a divisional of applicationSer. No. 13/420,735 filed on Mar. 15, 2012, which in turn claims thebenefit of priority to Provisional Application No. 61/453,654 filed onMar. 17, 2011, the content of which is relied upon and incorporatedherein by reference in its entirety, and the benefit of priority under35 U.S.C. § 120 is hereby claimed.

FIELD

The present disclosure relates to cell culture, and more particularly tosynthetic, chemically-defined coatings or surfaces and methods toprepare such coatings or surfaces.

BACKGROUND

Anchorage dependant cells are typically cultured in the presence ofsurfaces or media containing animal-derived components, such as feederlayers, serum, collagen, fibronectin, vitronectin, Matrigel™, and thelike, to facilitate anchoring of the cells to a surface.

One advantage of many animal-derived biological coatings is theirability to be prepared using simple protocols, which can be practicedwithout special and cumbersome equipment. For example, coatings madefrom cell adhesion proteins are performed by dissolving the proteins inwater at an appropriate concentration and pH, dispensing the appropriatevolume onto the surface of the article to be coated, incubating for anappropriate time and temperature, and rinsing to wash off the unboundmaterials. Typically, no chemical crosslinking step is required, whichavoids the use of specific chemical or physical processes for stableimmobilization of the cell adhesion proteins on the article surface.

However, animal-derived additions to the culture environment exposecells to potentially harmful viruses or other infectious agents, whichcould compromise general culture and maintenance of the cells and couldbe transferred to patients if the cells or products of the cells are tobe used for therapeutic purposes. In addition, such biological productsare vulnerable to batch variation, immune response and limitedshelf-life.

Therefore, methods of producing synthetic cell culture surfaces that arecapable of supporting cells in chemically defined or serum-free media,are desirable. This is particularly true for cells that may be used inpatients for therapeutic purposes, such as pluripotent stem cells, whichhave the ability to differentiate into any of the three germ layers,giving rise to any adult cell type.

To overcome the risk of contamination and batch variation, recombinantproteins having cell-adhesive properties have been proposed. However,such techniques are often complex, require extensive purification, andare expensive. Others have proposed in situ formation of swellablepolymers from monomers to which cell adhesive polypeptides may begrafted. However, such techniques require careful control of casting ofmonomers and solvent evaporation to produce homogenous surfaces, complexequipment for UV curing, and complex chemistry for polypeptide grafting.

Another way to solve the issues encountered with biological coatingsincludes coating water-insoluble polymers and associated cell adhesivepolypeptides or ligands on the surfaces of cell culture articles. Thepolymers and associated cell adhesive polypeptides are water-insolubleso that they do not release or dissolve in the presence of an aqueouscell culture medium. However, as the polymer-polypeptide/ligand polymersare water-insoluble, they cannot be used for coating from aqueoussolution as done usually with biological attachment factors. Inaddition, such processes tend to suffer from inhomogeneous coatingwithout careful control of dispensing and solvent evaporation and maynot be practicable with various formats such as large vessels or smallwells from multiwell plates due to variable evaporation rates occurringwithin such different formats.

There is still a need for a simple coating process using a syntheticpolymer to prevent potential xenogenic contamination and batch to batchvariability but that can be performed simply as usually done with animalderived biological attachment factors.

BRIEF SUMMARY

Among other things, the present disclosure describes methods for makingcell culture articles by contacting the articles with an aqueoussolution containing a synthetic polymer having a conjugated polypeptideand exposing the coated articles to heat or electromagnetic radiation toproduce a cell culture article with a cell attachment surface. Thesynthetic polymer and conjugated polypeptide described herein aresoluble in cold or room temperature water but become securely attachedto a substrate when exposed to heat or electromagnetic radiation, suchas UV light. The polymers are free of crosslinkers in many embodiments,yet the attachment strength of the synthetic polymer deposited to thesubstrate from aqueous solution is strong enough to resist stringentwashing with buffers or with surfactant aqueous solutions and may alsoresist delamination during ethanol sanitization. Being aqueous based,the synthetic compositions and methods described herein can, in manyembodiments, produce homogeneous coating surfaces similar to theiranimal derived counterparts, with less batch to batch variation andreduced potential for xenobiotic contamination.

In various embodiments described herein, a method for coating thesurface of a cell culture article includes dissolving a polymer having acovalently attached polypeptide in an aqueous solution to produce apolymer solution. The polymer is formed from monomers selected to form alinear polymer backbone. The polymer is free of crosslinks. The weightpercentage of the polypeptide relative to the polymer conjugated to thepolypeptide is sufficiently high to render the polymer conjugated to thepolypeptide water soluble. The aqueous solution is substantially free oforganic solvents. The method further includes (i) disposing the polymersolution on the surface of the cell culture article to produce a coatedarticle; and (ii) subjecting the coated article to sufficient heat orelectromagnetic radiation to attach the polymer conjugated to apolypeptide to the surface of the cell culture article.

One or more embodiments of the cell culture articles, compositions, ormethods described herein provide one or more advantages over prior cellculture articles, compositions, or methods for producing coated cellculture articles. For example, because the coating is fully synthetic,it does not suffer from batch variation, immune response, limitedshelf-life and risk of exposure of the cells to potentially harmfulviruses or other infectious agents which could be transferred topatients. The coating process is simple to practice and is comparable toprotocols performed with animal-derived biological attachment factors,not complex like other processes employing synthetic coatings. Further,the coating process does not require the use of expensive and cumbersomeequipment, such as equipment needed to apply an inert gas blanket orpurges. The process is aqueous based, and thus is cheaper and more userand environment friendly than processes requiring organic solvents. Thecompositions and methods enable coating of a wide range of vesselformats, which can be coated with high uniformity at low costs. Evencomplex 3D shaped substrates, such as beads or porous 3D materials, canbe coated using the compositions and processes described herein, whichis not the case with processes using in situ polymerization process.Another advantage over in situ polymerization processes includes theability to perform quality control review of the polymers before coatingto ensure that the composition of the coating is always the same.Additionally, due to the simplified coating process, composition can beprovided as a kit for use in coating by an end user in almost anylaboratory setting. These and other advantages will be readilyunderstood from the following detailed descriptions when read inconjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a reaction scheme for making a poly(MAA-PEG4-VN) homopolymerhaving a conjugated cell adhesive polypeptide.

FIG. 2 is a reaction scheme for making a poly(HEMA-co-MAA-PEG4-VN)copolymer having a conjugated cell adhesive polypeptide.

FIGS. 3A-B are schematic diagrams of side views of coated articles.

FIGS. 4A-C are schematic diagrams of cross sections of cell culturearticles having a well. Uncoated (4A); coated surface (4B); and coatedsurface and side walls (4C).

FIG. 5 is a bar graph showing the amount of immobilized copolymer ondifferent substrates measured by colloidal gold total protein staining.

FIG. 6 is a bar graph showing amount of immobilized peptide (pmol/mm²)quantified by BCA, for non-treated, TCT treated, CellBIND® treated andULA treated 6 well polystyrene plates coated in accordance to theteachings presented herein.

FIG. 7 is a bar graph showing the amount of immobilized copolymer on TCTsubstrate using different methods to immobilize the polymer such as UVlight exposure, and heating at 80° C. or 37° C. for 15 min or 6 hours,respectively.

FIG. 8 is a bar graph showing the amount of immobilized peptide(pmol/mm²) for TCT treated 6 well polystyrene plates coated inaccordance with the teachings provided herein and incubated at 37° C.for 6 hours, 80° C. for 15 min or exposed to 30 J/cm² UV-A at 40-50° C.

FIGS. 9A-C are photographs showing colloidal gold staining (ColloidalGold Total Protein Stain reagent available from Bio-Rad, Hercules,Calif.) of a T-75 flask (FIG. 9A), CellStack layer (FIG. 9B) and 6 wellplate (FIG. 9C) coated in accordance with the teachings presentedherein.

FIG. 10 is a photograph showing colloidal gold staining of a 96 wellplate coated in accordance with the teachings presented herein.

FIG. 11 is a graph showing the quantification of the colloidal goldstaining of the 96 well plate from FIG. 10.

FIGS. 12A-B are micrographs showing BG01v hESC colonies formed 3 daysafter seeding (in mTeSR1®) on Matrigel™ coated 6 wellplate (FIG. 12A)and on a plate coated with the coating according to an embodimentdescribed herein (FIG. 12B).

FIG. 13 is a table showing cell viability, fold expansion data for hMSCcultured on Corning Synthemax™, Mesencult™ attachment substrate and acoating according to an embodiment presented herein.

FIGS. 14A-D are photomicrographs showing morphology of bonemarrow-derived hMSC, 2 and 4 days after seeding on coating according toan embodiment described herein (FIG. 14A and FIG. 14B) and MesenCult®attachment substrate biological coating (FIG. 14C and FIG. 14D).

FIGS. 15A-D are photomicrographs of ESD3 mESC colonies formed after 1day from single cell seeding on non-treated polystyrene (FIG. 15D), TCTtreated polystyrene (FIG. 15A), CellBIND® treated polystyrene (FIG. 15B)and ULA treated polystyrene (FIG. 15C) plates coated in accordance withthe teachings presented herein.

FIGS. 16A-B are photomicrographs showing morphology of ESD3 mESCcolonies formed after 1 day from single cell seeding: (FIG. 16A) cellsseeded without ethanol sanitization; (FIG. 16B) cells seed following 1hour sanitization with 70% ethanol.

The schematic drawings in are not necessarily to scale. Like numbersused in the figures refer to like components, steps and the like.However, it will be understood that the use of a number to refer to acomponent in a given figure is not intended to limit the component inanother figure labeled with the same number. In addition, the use ofdifferent numbers to refer to components is not intended to indicatethat the different numbered components cannot be the same or similar.

DETAILED DESCRIPTION

In the following detailed description, reference is made to theaccompanying drawings that form a part hereof, and in which are shown byway of illustration several specific embodiments of devices, systems andmethods. It is to be understood that other embodiments are contemplatedand may be made without departing from the scope or spirit of thepresent disclosure. The following detailed description, therefore, isnot to be taken in a limiting sense.

All scientific and technical terms used herein have meanings commonlyused in the art unless otherwise specified. The definitions providedherein are to facilitate understanding of certain terms used frequentlyherein and are not meant to limit the scope of the present disclosure.

As used in this specification and the appended claims, the singularforms “a”, “an”, and “the” encompass embodiments having pluralreferents, unless the content clearly dictates otherwise. As used inthis specification and the appended claims, the term “or” is generallyemployed in its sense including “and/or” unless the content clearlydictates otherwise.

As used herein, “have”, “having”, “include”, “including”, “comprise”,“comprising” or the like are used in their open ended sense, andgenerally mean “including, but not limited to”. It will be understoodthat “consisting essentially of”, “consisting of”, and the like aresubsumed in “comprising” and the like.

As used herein, “conjugated,” as it relates to a monomer or polymer anda polypeptide, means that the polypeptide is covalently bound, eitherdirectly or indirectly (e.g., via a spacer) to the polymer or monomer.

As used herein, “monomer” means a compound capable of polymerizing withanother monomer, (regardless of whether the “monomer” is of the same ordifferent compound than the other monomer).

As used herein, a “(meth)acrylate monomer” means a methacrylate monomeror an acrylate monomer. As used herein “(meth)acrylamide monomer” meansa methacrylamide or an acrylamide monomer. (Meth)acrylate and(meth)acrylamide monomers have at least one ethylenically unsaturatedmoiety. “Poly(meth)acrylate”, as used herein, means a polymer formedfrom one or more monomers including at least one (meth)acrylate monomer.“Poly(meth)acrylamide”, as used herein, means a polymer formed from oneor more monomers including at least one (meth)acrylamide monomer.

As used herein, a polymer without conjugated polypeptide that is“substantially similar” to a polymer conjugated to the polypeptide is apolymer that formed in the same manner as the polymer conjugated to thepolymer conjugated to the polypeptide except that the polypeptide is notincluded. For example, a polypeptide may be conjugated to a polymer viagrafting after the polymer is formed. In such cases, the substantiallysimilar polymer that is not conjugated to the polypeptide is the polymerthat has not been grafted. By way of further example, a monomer may bederivatized with a polypeptide and the polypeptide may be incorporatedinto the polymer as the monomer is polymerized or copolymerized. In suchcases, the substantially similar polymer that is not conjugated to thepolypeptide is a polymer formed under the same reaction conditions asthe polymer conjugated to the polypeptide except that the monomer is notderivatized with the polypeptide.

Polypeptide sequences are referred to herein by their one letter aminoacid codes or by their three letter amino acid codes. These codes may beused interchangeably.

As used herein, “peptide” and “polypeptide” mean a sequence of aminoacids that may be chemically synthesized or may be recombinantlyderived, but that are not isolated as entire proteins from animalsources. For the purposes of this disclosure, peptides and polypeptidesare not whole proteins. Peptides and polypeptides may include amino acidsequences that are fragments of proteins. For example peptides andpolypeptides may include sequences known as cell adhesion sequences suchas RGD. Polypeptides may be of any suitable length, such as betweenthree and 30 amino acids in length. Polypeptides may be acetylated (e.g.Ac-LysGlyGly) or amidated (e.g.SerLysSer-NH₂) to protect them from beingbroken down by, for example, exopeptidases. It will be understood thatthese modifications are contemplated when a sequence is disclosed.

The present disclosure describes, inter alia, compositions and methodsfor coating cell culture articles by contacting the articles with anaqueous solution containing a synthetic polymer having a conjugatedpolypeptide and exposing the coated articles to heat or electromagneticradiation to produce a cell culture article with a cell attachmentsurface. The synthetic polymer and conjugated polypeptide describedherein are soluble in cold (e.g., less than 20° C.) or room temperature(25° C.) water but become securely attached to a substrate when exposedto heat or electromagnetic radiation, such as UV light. Despite thepolymers being free of crosslinkers in many embodiments, they attach tothe substrate with sufficient strength to resist stringent washing withbuffers or with surfactant aqueous solutions, and may also resistdelamination during ethanol sanitization. Being aqueous based, thesynthetic compositions and methods described herein can, in manyembodiments, produce homogeneous coating surfaces similar toanimal-derived cell adhesion factors, but with less batch to batchvariation and reduced potential for xenobiotic contamination.

Polymer

The polymers conjugated to polypeptide described herein are watersoluble at room temperature. However, in many embodiments, asubstantially similar polymer that is not conjugated to the polypeptideis not water soluble at room temperature. In such embodiments, thepolypeptide serves to render the polymers conjugated to polypeptidewater soluble. Preferably, the substantially similar polymer that is notconjugated to the polypeptide is not water soluble at cell culturetemperatures, which is typically 37° C. It may also be desirable for thepolymer to be swellable in water at 37° C., to provide a suitablemodulus for cell culture.

The polymers conjugated to the polypeptides may be formed by anysuitable process using any suitable monomers. In embodiments, the one ormore monomers used to form the polymer and the reaction mechanisms(e.g., step-growth polymerization or condensation polymerization, orchain polymerization or addition polymerization) used to form thepolymer are selected to form polymers with linear polymer backbones. Inembodiments, the resulting polymers are free of crosslinks.

In many embodiments, the monomers used to form the polymers contain anethylenically unsaturated group, such as (meth)acrylates,(meth)acrylamides, maleimides, fumurates, vinylsulfones, or the like.The polymers may be homopolymers or copolymers. The monomers may bechosen such that the polymer is insoluble in water at 37° C., but issoluble in water in the range of 4° C. to 25° C. when conjugated to thepolypeptide.

In various embodiments, a monomer employed is a (meth)acrylate monomerof Formula (I):

where A is H or methyl, and where B is H, C1-C6 straight or branchedchain alcohol or ether, or C1-C6 straight or branched chain alkylsubstituted with a carboxyl group (—COOH). In some embodiments, B isC1-C4 straight or branched chain alcohol. In some embodiments, B isstraight or branched chain C1-C3 substituted with a carboxyl group. Byway of example, 2-carboxyethyl methacrylate, 2-carboxyethyl acrylate,acrylic acid, methacrylic acid, hydroxypropyl methacrylate,2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, glycerolmethacrylate, hydroxypropyl acrylate, 4-hydroxybutyl acrylate, or thelike may be employed.

In various embodiments, a monomer employed is a (meth)acrylamide monomerof Formula (II):

where A is hydrogen or methyl, and where B is H, C1-C6 straight orbranched chain alcohol or ether, or C1-C6 straight or branched chainalkyl substituted with a carboxyl group (—COOH). In some embodiments, Bis straight or branched chain C1-C3 substituted with a carboxyl group.In some embodiments, B is C1-C4 straight or branched chain alcohol. Byway of example, 2-carboxyethyl acrylamide, acrylamidoglycolic acid,N-(hydroxymethyl)acrylamide, N-[Tris(hydroxymethyl)methyl]acrylamide,3-acryloylamino-1-propanol, N-acrylamido-ethoxyethanol, N-hydroxyethylacrylamide, or the like, may be used.

The monomer or monomers used to form the polymer may be selected toachieve a polymer having the desired characteristics (e.g., modulus,swellability, water solubility). For example, copolymers formed frommore than one monomer may have a greater degree of swellability thanhomopolymers formed from any one of the monomers alone. Generally,monomers having longer chain alkyl groups will tend to render thepolymer too water insoluble for the conjugated polypeptide to make thepolymer-polypeptide water soluble at appropriate temperatures.Additionally, monomers having moieties that favor hydrogen bonding orthat are charged at selected pH levels may tend to make the polymer morewater soluble. One of skill in the art will readily be able to selectthe appropriate monomers and monomer ratios for preparing polymershaving desired characteristics.

Once the appropriate monomers in the appropriate amounts are selected,the polymer may be formed via polymerization reaction. In addition tothe monomers that form the polymer, a composition may include one ormore additional compounds such as surfactants, wetting agents,photoinitiators, thermal initiators, catalysts, and activators.

Any suitable polymerization initiator may be employed. One of skill inthe art will readily be able to select a suitable initiator, e.g. aradical initiator or a cationic initiator, suitable for use with themonomers. In various embodiments, UV light is used to generate freeradical monomers to initiate chain polymerization. Examples ofpolymerization initiators include organic peroxides, azo compounds,quinones, nitroso compounds, acyl halides, hydrazones, mercaptocompounds, pyrylium compounds, imidazoles, chlorotriazines, benzoin,benzoin alkyl ethers, diketones, phenones, or mixtures thereof. Examplesof suitable commercially available, ultraviolet-activated and visiblelight-activated photoinitiators have tradenames such as IRGACURE 651,IRGACURE 184, IRGACURE 369, IRGACURE 819, DAROCUR 4265 and DAROCUR 1173commercially available from Ciba Specialty Chemicals, Tarrytown, N.Y.and LUCIRIN TPO and LUCIRIN TPO-L commercially available from BASF(Charlotte, N.C.)

A photosensitizer may also be included in a suitable initiator system.Representative photosensitizers have carbonyl groups or tertiary aminogroups or mixtures thereof. Photosensitizers having a carbonyl groupsinclude benzophenone, acetophenone, benzil, benzaldehyde,o-chlorobenzaldehyde, xanthone, thioxanthone, 9,10-anthraquinone, andother aromatic ketones. Photosensitizers having tertiary amines includemethyldiethanolamine, ethyldiethanolamine, triethanolamine,phenylmethyl-ethanolamine, and dimethylaminoethylbenzoate. Commerciallyavailable photosensitizers include QUANTICURE ITX, QUANTICURE QTX,QUANTICURE PTX, QUANTICURE EPD from Biddle Sawyer Corp.

In general, the amount of photosensitizer or photoinitiator system mayvary from about 0.01 to 10% by weight.

Examples of cationic initiators that may be employed include salts ofonium cations, such as arylsulfonium salts, as well as organometallicsalts such as ion arene systems.

Examples of free radical initiators that may be employed includeazo-type initiators such as 2-2′-azobis(dimethyl-valeronitrile),azobis(isobutyronitrile), azobis(cyclohexane-nitrite),azobis(methyl-butyronitrile), and the like, peroxide initiators such asbenzoyl peroxide, lauroyl peroxide, methyl ethyl ketone peroxide,isopropyl peroxy-carbonate,2,5-dienethyl-2,5-bas(2-ethylhexanoyl-peroxy)hexane, di-tert-butylperoxide, cumene hydroperoxide, dichlorobenzoyl peroxide, potassiumpersulfate, ammonium persulfate, sodium bisulfate, combination ofpotassium persulfate, sodium bisulfate and the like, and mixturesthereof. Of course, any other suitable free radical initiators may beemployed. An effective quantity of an initiator is generally within therange of from about 0.1 percent to about 15 percent by weight of thereaction mixture, such as from 0.1 percent to about 10 percent by weightor from about 0.1 percent to about 8 percent by weight of the reactionmixture.

In various embodiments, one or more monomers are diluted prior toundergoing polymerization.

The polymer resulting from the polymerization reaction may have anysuitable molecular weight. In various embodiments, the polymer haves anaverage molecular weight (Mw) of between 10,000 and 1000,000 Daltons,such as between 10,000 and 250,000 Daltons. One of skill in the art willunderstand that the amount of initiator, reaction time, reactiontemperature, and the like may be varied to adjust the molecular weightof the resulting polymer.

(Meth)acrylate monomers, (meth)acrylamide monomers, or other suitablemonomers may be synthesized as known in the art or obtained from acommercial vendor, such as Polysciences, Inc., Sigma Aldrich, Inc., andSartomer, Inc.

Polypeptide Incorporation

The polypeptide may be conjugated to the polymer in any suitable manner.In some embodiments a monomer is derivatized to include the polypeptideand, thus, the polypeptide is incorporated into the polymer as it isbeing formed. In some embodiments, the polypeptide is grafted to thepolymer after the polymer is formed.

Referring now to FIGS. 1-2 examples of reaction schemes forincorporating a polypeptide into a polymer as it is being formed isshown. In FIG. 1, a vitronectin polypeptide (VN) is conjugated tomethacrylate (MAA) via a repeating polyethylene glycol (PEG₄) spacer. Ahomopolymer is produced by polymerizing the monomer (MMA) that isconjugated to the polypeptide (VN) under appropriate conditions. In thedepicted embodiment, ethanol is the solvent,2,2′-Azodi(2-methylbutyronitrile) (AMBN) is the thermal initiator, thereaction temperature is 68° C., and the reaction is carried out underargon.

A monomer may be derivatized to include a polypeptide using any suitableprocess, such as described in Example 1 presented herein. Well knownprocesses for preparing polypeptide-monomers are described inUS2007/0190036, published on Aug. 16, 2007, naming Kizilel, S., et al.as inventors. Of course, other methods for derivatizing a monomer with apolypeptide may be used.

In the embodiment depicted in FIG. 2, a copolymer is formed from2-hydroxyethylmethacrylate (HEMA) and MMA-PEG₄-VN under similar reactionconditions to those described with regard to FIG. 1 above. The use ofmultiple monomers to produce the polymer allows one to more readily tunethe properties of the resulting polymer as desired, regardless ofwhether the polypeptide is incorporated into the polymer as the polymeris formed.

In various embodiments, a polypeptide is grafted to a polymer that hasalready been formed. Preferably, polypeptide includes an amino acidcapable of conjugating to a pendant reactive group of the polymer.Examples of reactive groups that the polymer may have for reaction witha polypeptide include maleimide, glycidyl, isocyanate, isothiocyante,activated esters, activated carbonates, anhydride, and the like. By wayof example, any native or biomimetic amino acid having functionalitythat enables nucleophilic addition; e.g. via amide bond formation, maybe included in polypeptide for purposes of conjugating to thepolypeptide having a suitable reactive group. Lysine, homolysine,ornithine, diaminoproprionic acid, and diaminobutanoic acid are examplesof amino acids having suitable properties for conjugation to a reactivegroup of the polymer, such as carboxyl group. In addition, theN-terminal alpha amine of a polypeptide may be used to conjugate to thecarboxyl group, if the N-terminal amine is not capped. In variousembodiments, the amino acid of polypeptide that conjugates with themicrocarrier is at the carboxy terminal position or the amino terminalposition of the polypeptide.

A polypeptide may be conjugated to the polymer via any suitabletechnique. A polypeptide may be conjugated to a polymer via an aminoterminal amino acid, a carboxy terminal amino acid, or an internal aminoacid. One suitable technique involves 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC)/N-hydroxysuccinimide (NHS) chemistry,as generally known in the art. EDC and NHS or N-hydroxysulfosuccinimide(sulfo-NHS) can react with free carboxyl groups of the polymer toproduce amine reactive NHS esters. EDC reacts with a carboxyl group ofthe polymer to produce an amine-reactive O-acylisourea intermediate thatis susceptible to hydrolysis. The addition of NHS or sulfo-NHSstabilizes the amine-reactive O-acylisourea intermediate by convertingit to an amine reactive NHS or sulfo-NHS ester, allowing for a two-stepprocedure. Following activation of the polymer, the polypeptide may thenbe added and the terminal amine of the polypeptide can react with theamine reactive ester to form a stable amide bond, thus conjugating thepolypeptide to the polymer layer. When EDC/NHS chemistry is employed toconjugate a polypeptide to the polymer, the N-terminal amino acid ispreferably an amine containing amino acid such as lysine, ornithine,diaminobutyric acid, or diaminoproprionic acid. Of course, anyacceptable nucleophile may be employed, such as hydroxylamines,hydrazines, hydroxyls, and the like.

EDC/NHS chemistry results in a zero length crosslinking of polypeptideto microcarrier. Linkers or spacers, such as poly(ethylene glycol)linkers (e.g., available from Quanta BioDesign, Ltd.) with a terminalamine may be added to the N-terminal amino acid of polypeptide. Whenadding a linker to the N-terminal amino acid, the linker is preferably aN-PG-amido-PEGx-acid where PG is a protecting group such as the Fmocgroup, the BOC group, the CBZ group or any other group amenable topeptide synthesis and X is 2, 4, 6, 8, 12, 24 or any other discrete PEGwhich may be available.

Of course, any other suitable mechanism for grafting the polypeptide tothe polymer may be used. In addition, any suitable space may be used. Alinker or spacer, such as a repeating poly(ethylene glycol) linker orany other suitable linker, may be used to increase distance frompolypeptide to surface of polymer. The linker may be of any suitablelength. For example, if the linker is a repeating poly(ethylene glycol)linker, the linker may contain between 2 and 10 repeating ethyleneglycol units. In some embodiments, the linker is a repeatingpoly(ethylene glycol) linker having about 4 repeating ethylene glycolunits. All, some, or none of the polypeptides may be conjugated to apolymer via linkers. Other potential linkers that may be employedinclude polypeptide linkers such as poly(glycine) or poly(β-alanine).

A linker may serve to provide better accessibility of the polypeptide tocells when used in cell culture. In addition, the use of a linker inembodiments where the polypeptide is conjugated to a monomer, theefficiency of polymerization of the monomer into a homopolymer orcopolymer may be increased.

The polypeptide may be cyclized or include a cyclic portion. Anysuitable method for forming cyclic polypeptide may be employed. Forexample, an amide linkage may be created by cyclizing the free aminofunctionality on an appropriate amino-acid side chain and a freecarboxyl group of an appropriate amino acid side chain. Also, adi-sulfide linkage may be created between free sulfydryl groups of sidechains appropriate amino acids in the peptide sequence. Any suitabletechnique may be employed to form cyclic polypeptides (or portionsthereof). By way of example, methods described in, e.g., WO1989005150may be employed to form cyclic polypeptides. Head-to-tail cyclicpolypeptides, where the polypeptides have an amide bond between thecarboxy terminus and the amino terminus may be employed. An alternativeto the disulfide bond would be a diselenide bond using twoselenocysteines or mixed selenide/sulfide bond, e.g., as described inKoide et al, 1993, Chem. Pharm. Bull. 41(3):502-6; Koide et al., 1993,Chem. Pharm. Bull. 41(9):1596-1600; or Besse and Moroder, 1997, Journalof Peptide Science, vol. 3, 442-453.

Polypeptides may be synthesized as known in the art (or alternativelyproduced through molecular biological techniques) or obtained from acommercial vendor, such as American Peptide Company, CEM Corporation, orGenScript Corporation. Linkers may be synthesized as known in the art orobtained from a commercial vendor, such as discrete polyethylene glycol(dPEG) linkers available from Quanta BioDesign, Ltd.

In various embodiments, the polypeptide, or a portion thereof, has celladhesive activity; i.e., when the polypeptide is conjugated to thepolymer, the polypeptide allows a cell to adhere to the surface of thepeptide-containing polymer. By way of example, the polypeptide mayinclude an amino sequence, or a cell adhesive portion thereof,recognized by proteins from the integrin family or leading to aninteraction with cellular molecules able to sustain cell adhesion. Forexample, the polypeptide may include an amino acid sequence derived fromcollagen, keratin, gelatin, fibronectin, vitronectin, laminin, bonesialoprotein (BSP), or the like, or portions thereof. In variousembodiments, polypeptide includes an amino acid sequence of ArgGlyAsp(RGD).

For any of the polypeptides discussed herein, it will be understood thata conservative amino acid may be substituted for a specificallyidentified or known amino acid. A “conservative amino acid”, as usedherein, refers to an amino acid that is functionally similar to a secondamino acid. Such amino acids may be substituted for each other in apolypeptide with a minimal disturbance to the structure or function ofthe polypeptide according to well-known techniques. The following fivegroups each contain amino acids that are conservative substitutions forone another: Aliphatic: Glycine (G), Alanine (A), Valine (V), Leucine(L), Isoleucine (I); Aromatic: Phenylalanine (F), Tyrosine (Y),Tryptophan (W); Sulfur-containing: Methionine (M), Cysteine (C); Basic:Arginine (R), Lysine (K), Histidine (H); Acidic: Aspartic acid (D),Glutamic acid (E), Asparagine (N), Glutamine (Q).

One or more polypeptide may be conjugated to a polymer, whether graftedor incorporated during polymer formation, in any suitable amount.Preferably, weigh percentage of the polypeptide is sufficiently high torender the polymer conjugated to the polymer water soluble. In variousembodiments, the weight percentage of the polypeptide relative to thepolymer conjugated to the polypeptide is 40% or greater, such as 60% orgreater. Such weight percentages have been determined to achieve goodwater solubility, immobilization efficiency and acceptable cell adhesionfor polypeptides having a molecular weight of 1500 Daltons or higher.

Polymers as described herein provide a synthetic surface to which anysuitable adhesion polypeptide or combinations of polypeptides may beconjugated, providing an alternative to biological substrates or serumthat have unknown components. In current cell culture practice, it isknown that some cell types require the presence of a biologicalpolypeptide or combination of peptides on the culture surface for thecells to adhere to the surface and be sustainably cultured. For example,HepG2/C3A hepatocyte cells can attach to plastic culture ware in thepresence of serum. It is also known that serum can provide polypeptidesthat can adhere to plastic culture ware to provide a surface to whichcertain cells can attach. However, biologically-derived substrates andserum contain unknown components. For cells where the particularcomponent or combination of components (peptides) of serum orbiologically-derived substrates that cause cell attachment are known,those known polypeptides can be synthesized and applied to a polymer asdescribed herein to allow the cells to be cultured on a syntheticsurface having no or very few components of unknown origin orcomposition.

Coating Composition

The polymer conjugated to the polypeptide may be dissolved in an aqueoussolution for use in coating cell culture articles. The aqueous solutionis free, or substantially free, of organic solvents. It will beunderstood that some minor amounts of organic solvents may be present inthe aqueous solution, for example as a result some organic solventremaining in the polymer after polymerization. As used herein,“substantially free,” as it relates to an organic solvent in an aqueoussolution, means that the aqueous solution comprises less than 2% of theorganic solvent by weight. In many embodiments, the aqueous solutioncontains less than 1%, less than 0.5%, less that 0.2% or less that 0.1%of an organic solvent. Examples of organic solvents from which theaqueous solution is free include methanol, ethanol, butanol, propanol,octanol, hexane, heptane, acetone, acetyl acetate, ethyl acetate,dimethylformamide (DMF), dimethylsulfoxide (DMSO), and the like.

The polymer conjugated to the polypeptide may be dissolved in theaqueous solution at any suitable concentration for purposes of coating.For example, the aqueous solution may contain between 0.1 mg/ml and 0.5mg/ml of the polymer conjugated to the polypeptide, such as between 0.2mg/ml and 0.3 mg/ml of the polymer conjugated to the polypeptide, orabout 0.25 mg/ml of the polymer conjugated to the polypeptide.

In many embodiments, the aqueous solution consists essentially of, orconsists of, water and the dissolved polymer conjugated to thepolypeptide. Of course, the solution may be a pH buffered solution, suchas a phosphate buffered solution, may contain osmolarity adjustmentagents, such as sodium chloride, potassium chloride, calcium chloride,or the like, or may include surfactants or other suitable agents.

The aqueous solution is preferably free or substantially free ofcross-linking agents. As used herein, “cross-linking agent” refers to anagent capable of inducing cross-linking in, or capable of cross-linking,the polymer portion of the polymer-polypeptide. As used herein,“substantially free” as it relates to cross-linking agents, means thatno appreciable crosslinking occurs in the polymer as a result of thepresence of trace amounts of a crosslinking agent. Examples ofcross-linkers that the polymer portion is substantially free frominclude well known crosslinking agents include homo-multifunctional orhetero-multifunctional crosslinking agent as those described in“Bioconjugate Techniques, Second Edition by Greg T. Hermanson”. Thecomposition is also “substantially free” of multifunctional oligomersand polymers that could lead to formation of interpenetrated network orsemi-interpenetrated network.

Coating Process

The polymer conjugated to the polypeptide may be coated onto a cellculture article in any suitable manner. Generally, an aqueous solutioncontaining the polymer conjugated to the polypeptide, as describedabove, is disposed on a surface of the cell culture article. The aqueoussolution may be sprayed onto the surface of the article, may be pouredon the surface of the article, or the like. In some embodiments, thearticle is submerged and removed from the aqueous solution.

Once the aqueous solution is disposed on the surface of the article, thecoated article is subjected to sufficient heat or electromagneticradiation to attach the polymer conjugated to the polypeptide to thesurface of the article. While it is possible to covalently attach thepolymer to the surface of the article, the polymer will typically beattached to the article via non covalent interactions. Examples ofnon-covalent interactions that may attach the polymer with the substrateinclude chemical adsorption, hydrogen bonding, surface interpenetration,ionic bonding, van der Waals forces, hydrophobic interactions,dipole-dipole interactions, mechanical interlocking, and combinationsthereof. Preferably, the polymer attaches to the surface of the articlesuch that it does not delaminate or dissolve during cell cultureconditions, such as in the presence of cell culture media at 37° C. Invarious embodiments, the coated article is subjected to a sufficientamount of heat or electromagnetic energy to attach the polymer to thesurface of the cell culture article such that greater than 90% of thepolymer-polypeptide remains attached to the surface after incubation inwater for one week at 37° C. Preferably, greater than 95%, or greaterthan 99%, of the polymer-polypeptide remains attached.

Any suitable amount of heat or electromagnetic radiation may be used.For example, the cell culture article may be incubated at temperaturesfrom room temperature to about 80° C. for a period of time from severalminutes to several hours. For example, it has been found that coatedcell culture articles incubated at 80° C. for 15 min or 37° C. for 6hours showed good attachment of the polymer to the article surface.Alternatively, or in addition, the coated cell culture article may beexposed to electromagnetic energy, such as UV light. It has been foundthat coated articles illuminated with UV light under ambient atmosphereshow good attachment. By way of example, a fusion lamp equipped with a“D” bulb at a dose of 20 to 30 J/cm² UVA at a temperature of about 40°C. to about 50° C. may be used. To avoid degradation of the polypeptideby highly energetic low wavelength radiation, a filter screeningwavelengths below 300 nm may be placed between the light source and thecoating composition. In the case of a polystyrene well plate, its lid orbottom plate can be advantageously used as an effective filter blockingthe potentially deleterious low wavelength radiation.

Without intending to be bound to any particular theory, it is believedthat the high percentage of polypeptide relative to the polymer aids inthe surprising adsorption of the polymer on appropriate substrates froman aqueous solution and its non-solubility in water after adsorption.The high polypeptide content may lead to a high density of hydrogenbonding between polypeptides, inducing physical crosslinking oraggregation, which is a behaviour similar to natural occurring proteins.It is also well-known that some specific polypeptides are soluble inaqueous solution below their transition temperature, but theyhydrophobically collapse and aggregate when the temperature is raisedabove the transition temperature. Such hydrophobic collapse may play arole in adsorption of polymers conjugated with polypeptides that aresubjected to heating. In any case, it has been found that exposure toheat or electromagnetic radiation results in good polymer-polypeptideadsorption to the surface of cell culture articles.

The surface of the cell culture article to which the polymer conjugatedto the polypeptide is coated may be formed of any suitable material. Forexample, the surface of the cell culture article may be formed from aceramic substance, a glass, a plastic, a polymer or copolymer, anycombinations thereof, or a coating of one material on another. Such basematerials include glass materials such as soda-lime glass, pyrex glass,vycor glass, quartz glass; silicon; plastics or polymers, includingdendritic polymers, such as poly(vinyl chloride), poly(vinyl alcohol),poly(methyl methacrylate), poly(vinyl acetate-co-maleic anhydride),poly(dimethylsiloxane) monomethacrylate, cyclic olefin polymers,fluorocarbon polymers, polystyrenes, polypropylene, polyethyleneimine;copolymers such as poly(vinyl acetate-co-maleic anhydride),poly(styrene-co-maleic anhydride), poly(ethylene-co-acrylic acid) orderivatives of these or the like.

It has been found that good attachment of the polymer-polypeptide to thesurface of the cell culture article is achieved when the substrateexhibits a water contact angle (sessile drop measurement) between 12°and 85°. Preferably the contact angle of the substrate is between 25°and 70°, such as between 30° and 60°. It will be understood thatsubstrates may be treated so that they exhibit an appropriate contactangle. For example, the substrate may be corona treated or plasmatreated. Examples of vacuum or atmospheric pressure plasma include RFand microwave plasmas both primary and secondary, dielectric barrierdischarge, and corona discharge generated in molecular or mixed gasesincluding air, oxygen, nitrogen, argon, carbon dioxide, nitrous oxide,or water vapor. By way of example, plasma treated polystyrene, such asTCT polystyrene or CellBIND® treated polystyrene provide good substratesfor polymer-polypeptide attachment. Naturally occurring animal-derivedbiological adhesive proteins also exhibit good binding to such surfaces.Accordingly, surfaces to which naturally occurring proteins readilyattach may also provide good substrates for polymer-polypeptideattachment.

Cell Culture Article

A polymer conjugated to a polypeptide as described herein may beattached to the surface of any suitable cell culture article, such assingle and multi-well plates, such as 6, 12, 96, 384, and 1536 wellplates, jars, petri dishes, flasks, beakers, plates, roller bottles,slides, such as chambered and multichambered culture slides, tubes,cover slips, bags, membranes, hollow fibers, beads and microcarriers,cups, spinner bottles, perfusion chambers, bioreactors, CellSTACK® andfermenters.

Referring to FIG. 3A, a schematic diagram of a side view of an article100 for culturing cells is shown. The article 100 includes a basematerial substrate 10 having a surface 15. A polymer 20 conjugated to apolypeptide 70 is disposed on the surface 15 of the base material 10. Asdepicted, the polypeptide 70 may be conjugated or covalently bound tothe polymer 20 directly or indirectly via linker 80 as described above.While not shown, it will be understood that the polymer 20 conjugated tothe polypeptide 70 may be disposed on a portion of base material 10. Thebase material 10 may be any material suitable for culturing cells, suchas those described above.

As shown in FIG. 3B, an intermediate layer 30 may be disposed betweensurface 15 of base material 10 and the coated polymer 20 conjugated tothe polypeptide 70. Intermediate layer 30 may be configured to improvebinding of the coated polymer 20 conjugated to the polypeptide 70 to thesubstrate 10, to facilitate spreading of the aqueous solution containingthe polymer conjugated to the polypeptide, to render portions of thesurface 10 that are uncoated cytophobic to encourage cell growth oncoated areas, to provide topographical features if desired through, forexample, patterned printing, or the like. For example, if substrate 10is a glass substrate, it may be desirable to treat a surface of theglass substrate with an epoxy coating or a silane coating. For variouspolymer base materials 10 it may be desirable to provide an intermediatelayer 30 of polyamide, polyimide, polypropylene, polyethylene, orpolyacrylate. While not shown, it will be understood that the coatedpolymer 20 conjugated to the polypeptide 70 may be disposed on a portionof intermediate layer 30. It will be further understood thatintermediate layer 30 may be disposed on a portion of base material 10.

Article 100, in numerous embodiments, is cell culture ware having awell, such as a Petri dish, a multi-well plate, a flask, a beaker orother container having a well. Referring now to FIG. 4A, article 100formed from base material 10 may include one or more wells 50. Well 50includes a sidewall 55 and a surface 15.

Referring to FIG. 4B-C, a polymer 20 conjugated to a polypeptide 70 maybe disposed on surface 15 or sidewalls 55 (or, as discussed above withregard to FIG. 1 one or more intermediate layer 30 may be disposedbetween surface 15 or sidewall 55 and coated polymer 20 conjugated tothe polypeptide 70) or a portion thereof. As shown in FIG. 4C, sidewalls55 may be coated with polymer 20 conjugated to polypeptide 70.

In various embodiments, surface 15 of base material 10 is treated,either physically or chemically, to impart a desirable property orcharacteristic to the surface 15. For example, and as discussed above,surface 15 may be corona treated or plasma treated.

The coated polymer 20 conjugated to the polypeptide 70, whether disposedon an intermediate layer 30 or base material 10, preferably uniformlycoats the underlying substrate. By “uniformly coated”, it is meant thatthe layer 20 in a given area, for example a surface of a well of aculture plate, completely coats the area at a thickness of about 5 nm orgreater. While the thickness of a uniformly coated surface may varyacross the surface, there are no areas of the uniformly coated surfacesthrough which the underlying layer (either intermediate layer 30 or basematerial 10) is exposed. Cell responses across non-uniform surfaces tendto be more variable than cell responses across uniform surfaces.

In various embodiments, article 100 includes a uniformly coated layer 20having a surface 25 with an area greater than about 5 mm². When the areaof the surface 15 is too small, reliable cell responses may not bereadily observable because some cells, such as human embryonic stemcells, are seeded as colonies or clusters of cells (e.g., having adiameter of about 0.5 mm) and adequate surface is desirable to ensureattachment of sufficient numbers of colonies to produce a quantitativecell response. In numerous embodiments, an article 100 has a well 50having a uniformly coated surface 15, where the surface 15 has an areagreater than about 0.1 cm², greater than about 0.3 cm², greater thanabout 0.9 cm², or greater than about 1 cm².

Incubating Cells on Synthetic Polymer Containing Conjugated Polypeptide

A cell culture article having a polymer containing a conjugatedpolypeptide as described above may be seeded with cells. The cells maybe of any cell type. For example, the cells may be connective tissuecells such as epithelial and endothelial cells, hepatocytes, skeletal orsmooth muscle cells, heart muscle cells, intestinal cells, kidney cells,or cells from other organs, stem cells, islet cells, blood vessel cells,lymphocytes, cancer cells, or the like. The cells may be mammaliancells, preferably human cells, but may also be non-mammalian cells suchas bacterial, yeast, or plant cells.

In numerous embodiments, the cells are stem cells which, as generallyunderstood in the art, refer to cells that have the ability tocontinuously divide (self-renewal) and that are capable ofdifferentiating into a diverse range of specialized cells. In someembodiments, the stem cells are multipotent, totipotent, or pluripotentstem cells that are isolated from an organ or tissue of a subject. Suchcells are capable of giving rise to a fully differentiated or maturecell types. A stem cell may be a bone marrow-derived stem cell,autologous or otherwise, a neuronal stem cell, or an embryonic stemcell. A stem cell may be nestin positive. A stem cell may be ahematopoeietic stem cell. A stem cell may be a multi-lineage cellderived from epithelial and adipose tissues, umbilical cord blood,liver, brain or other organ. In various embodiments, the stem cells areundifferentiated stem cells, such as undifferentiated embryonic stemcells.

Prior to seeding cells, the cells may be harvested and suspended in asuitable medium, such as a growth medium in which the cells are to becultured once seeded onto the surface. For example, the cells may besuspended in and cultured in a serum-containing medium, a conditionedmedium, or a chemically-defined medium. As used herein,“chemically-defined medium” means cell culture media that contains nocomponents of unknown composition. Chemically defined media may, invarious embodiments, contain no proteins, hydrosylates, or peptides ofunknown composition. In some embodiments, conditioned media containspolypeptides or proteins of known composition, such as recombinantgrowth hormones. Because all components of chemically-defined media havea known chemical structure, variability in culture conditions and thuscell response can be reduced, increasing reproducibility. In addition,the possibility of contamination is reduced. Further, the ability toscale up is made easier due, at least in part, to the factors discussedabove. Chemically defined cell culture media are commercially availablefrom Invitrogen (Invitrogen Corporation, 1600 Faraday Avenue, PO Box6482, Carlsbad, Calif. 92008) as STEM PRO, a fully serum- andfeeder-free (SFM) specially formulated from the growth and expansion ofembryonic stem cells, and Stem Cell Technologies, Inc. as mTeSR™1maintenance media for human embryonic stem cells. Anotherchemically-defined medium is MesenCult®-XF Medium which is astandardized, xeno-free, serum-free medium for the culture of humanmesenchymal stem cells (MSCs). MesenCult®-XF Medium is available fromSTEMCELL Technologies Inc.

One or more growth or other factors may be added to the medium in whichcells are incubated with the synthetic hydrogel layer. The factors mayfacilitate cellular proliferation, adhesion, self-renewal,differentiation, or the like. Examples of factors that may be added toor included in the medium include muscle morphogenic factor (MMP),vascular endothelium growth factor (VEGF), interleukins, nerve growthfactor (NGF), erythropoietin, platelet derived growth factor (PDGF),epidermal growth factor (EGF), activin A (ACT), hematopoietic growthfactors, retinoic acid (RA), interferons, fibroblastic growth factors,such as basic fibroblast growth factor (bFGF), bone morphogeneticprotein (BMP), peptide growth factors, heparin binding growth factor(HBGF), hepatocyte growth factor, tumor necrosis factors, insulin-likegrowth factors (IGF) I and II, transforming growth factors, such astransforming growth factor-β1 (TGFβ1), and colony stimulating factors.

The cells may be seeded at any suitable concentration. Typically, thecells are seeded at about 10,000 cells/cm² of substrate to about 500,000cells/cm². For example, cells may be seeded at about 50,000 cells/cm² ofsubstrate to about 150,000 cells/cm². However, higher and lowerconcentrations may readily be used. The incubation time and conditions,such as temperature, CO₂ and O₂ levels, growth medium, and the like,will depend on the nature of the cells being cultured and can be readilymodified. The amount of time that the cells are incubated on the surfacemay vary depending on the cell response desired.

The cultured cells may be used for any suitable purpose, including (i)obtaining sufficient amounts of undifferentiated stem cells cultured ona synthetic surface in a chemically defined medium for use ininvestigational studies or for developing therapeutic uses, (ii) forinvestigational studies of the cells in culture, (iii) for developingtherapeutic uses, and (iv) for therapeutic purposes.

Overview of Aspects of Disclosure

In a first aspect, a method for coating a surface of a cell culturearticle includes dissolving a polymer having a covalently attachedpolypeptide in an aqueous solution to produce a polymer solution. Thepolymer is formed from monomers selected to form a polymer having alinear backbone. The polymer is free of crosslinks. The weightpercentage of the polypeptide relative to the polymer conjugated to thepolypeptide is sufficiently high to render the polymer conjugated to thepolypeptide water soluble. The aqueous solution is substantially free oforganic solvents. The method further includes (i) disposing the polymersolution on the surface of the cell culture article to produce a coatedarticle; and (ii) subjecting the coated article to sufficient heat orelectromagnetic radiation to attach the polymer conjugated to apolypeptide to the surface of the cell culture article.

A second aspect is a method of the first aspect, wherein a substantiallysimilar polymer that it not conjugated to the polypeptide is insolublein water at 25° C.

A third aspect is a method of the first or second aspect, wherein theweight percentage of the polypeptide relative to the polymer conjugatedto the polypeptide is greater than 40%.

A fourth aspect is a method of the first or second aspect, wherein theweight percentage of the polypeptide relative to the polymer conjugatedto the polypeptide is greater than 60%.

A fifth aspect is a method of any of the first four aspects, wherein thepolypeptide is a cell adhesive polypeptide.

A sixth aspect is a method of any of the first four aspects, wherein thepolypeptide comprises an RGD sequence.

A seventh aspect is a method of any of the first four aspects, whereinthe polypeptide is a selected from the group of a vitronectinpolypeptide, a collagen polypeptide, of a laminin polypeptide, a bonesialoprotein polypeptide, and a fibronectin polypeptide.

An eighth aspect is a method of any of the first four aspects, whereinthe polypeptide is a vitronectin polypeptide.

A ninth aspect is a method according to any of the preceding aspects,wherein the polymer is formed from at least one monomer comprising aconjugated polypeptide.

A tenth aspect is a method of the ninth aspect, wherein the at least onemonomer comprising a conjugated polypeptide is methacrylic acid.

An eleventh aspect is a method of any of the preceding aspects, whereinthe polymer is formed from polymerization of (i) methacrylic acidconjugated to the polypeptide and (ii) hydroxyethylmethacrylate.

A twelfth aspect is a method of any of the first ten aspects, whereinthe polymer is formed from polymerization of a (i) monomer comprising amethacrylic acid functional group and (ii) hydroxyethylmethacrylate.

A thirteenth aspect is a method of any of the preceding aspects, whereinthe polymer conjugated to the polypeptide has a molecular weight ofbetween 10 kilodaltons and 1000 kilodaltons.

A fourteenth aspect is a method of any of the preceding aspects, whereinthe polymer solution comprises between 0.1 mg/ml and 0.5 mg/ml of thepolymer conjugated to the polypeptide.

A fifteenth aspect is a method of any of the preceding aspects, whereinthe polymer solution comprises between 0.2 mg/ml and 0.3 mg/ml of thepolymer conjugated to the polypeptide.

A sixteenth aspect is a method of any of the preceding aspects, whereinsubjecting the coated article to sufficient heat or electromagneticradiation comprises incubating the coated article at a temperature of37° C. or greater.

A seventeenth aspect is a method of any of the preceding aspects,wherein subjecting the coated article to sufficient heat orelectromagnetic radiation comprises incubating the coated article at atemperature of 60° C. or greater.

A eighteenth aspect is a method of any of the preceding aspects, whereinsubjecting the coated article to sufficient heat or electromagneticradiation comprises subjecting the coated article to UV radiation.

A nineteenth aspect is a method of any of the preceding aspects, whereinthe surface of the substrate has a water contact angle between 12° and85°.

A twentieth aspect is a method of any of the preceding aspects, whereinthe surface of the substrate has a water contact angle between 25° and70°.

A twenty-first aspect is a method of any of the preceding aspects,wherein the surface of the substrate has a water contact angle between30° and 60°.

A twenty-second aspect is a method of any of the preceding aspects,wherein the surface of the substrate is a plasma treated polystyrenesurface.

A twenty-third aspect is a cell culture article produced according to amethod of any of the preceding aspects.

A twenty-fourth aspect is a composition comprising an aqueous solutionand a polymer conjugated to a polypeptide dissolved in the aqueoussolution. The polymer is formed from monomers selected to form a polymerhaving a linear backbone. The polymer is free of crosslinks. Asubstantially similar polymer that it not conjugated to the polypeptideis insoluble in water at 37° C. The weight percentage of the polypeptiderelative to the polymer conjugated to the polypeptide is sufficientlyhigh to render the polymer conjugated to the polypeptide water soluble.The composition is substantially free of organic solvents.

A twenty-fifth aspect is a composition of the twenty-fourth aspect,wherein the polymer is formed from polymerization of (i) methacrylicacid conjugated to the polypeptide and (ii) hydroxyethylmethacrylate.

In the following, non-limiting examples are presented, which describevarious embodiments of the articles and methods discussed above.

EXAMPLES Example 1: Preparation of (MAA-PEG4-VN)

Methacrylic acid-(polyethylene glycol)₄-vitronectin (MMA-PEG4-VN) wasprovided by American Peptide, Sunnyvale, Calif. and was synthesized asfollows. The VN polypeptide sequence was KGGPQVTRGDVFTMP (SEQ ID NO:1).

Briefly, the polypeptide-monomer was synthesized on 1 mmol Fmoc-RinkAmide resin via Fmoc chemistry. Protecting groups used for amino acidsare: t-Butyl group for and Asp and Thr, Trt group for Gln, Pbf for Arg,Boc for Lys. Fmoc protected amino acids were purchased from EMDBiosciences; Fmoc-PEG4-OH was purchased from Quanta Biodesign. Reagentsfor coupling and cleavage were purchased from Aldrich. Solvents werepurchased from Fisher Scientific. The peptide chain was assembled onresin by repetitive removal of the Fmoc protecting group and coupling ofprotected amino acid. HBTU and HOBt were used as coupling reagents andNMM was used as base. 20% piperidine in DMF was used as de-Fmoc-reagent.Methacrylic acid (MAA) was coupled to the amino group of PEG4 afterremoval of the Fmoc protecting group. After the last coupling, the resinwas treated with TFA/TIS/H2O (95:3:2, v/v/v) for cleavage and removal ofthe side chain protecting groups. Crude polypeptide-monomer wasprecipitated from cold ether and collected by filtration. Crudepolypeptide-monomer was purified by reverse-phase HPLC. Collectedfractions with purity over 90% were pooled and lyophilized. The yield ofthe final product was 1.035 g (purification yield 25.9%). The productswere provided by American Peptide in ≥90% purity and were used withoutfurther purification.

Example 2: Preparation of Functionalized Cell Adhesive Polymer

Hydroxyethyl methacrylate (HEMA), 60 mg (0.46 mmol), and MAA-PEO4-VN,100 mg (0.05 mmol) were added to 7.5 ml ethanol in an amber flaskequipped with a stir bar. Then 2, 2′-Azobis-(2-Methylbutyronitrile), 9mg, was added and stirred until completed dissolution. The solution wasdeoxygenated with an argon purge for 1 minute. The sealed flask was thenheated for 24 hours at 68° C. under mixing and protected from light.After cooling to room temperature, the poly(HEMA-co-MAA-PEO4-VN) polymerwas isolated by pouring the crude reaction medium in ethylacetate. Thewhite solid obtained was washed three times with diisopropyl ether andfreeze dried.

The molecular weight of the poly(HEMA-co-MAA-PEO4-VN) polymer wasdetermined by size exclusion chromatography (SEC) coupled with arefractive Index detector, a light scattering detector, a photodiodearray detector and a viscometer detector. The mobile phase wastrifluoroethanol+potassium trifluoroacetate. Average Mw was 80,000 to100,000 and Mn was 25,000 to 33,000 and PDI was 2.8.

Although used herein without any purification, unreacted monomers ormonomer-peptides can be easily removed from thepoly(HEMA-co-MAA-PEO4-VN) polymer by means of well known processes suchas a continuous or discontinuous diafiltration process. Particularlyefficient unreacted peptide removal can be performed using for example a5,000 MWCO Corning Spin-X concentrator column.

The resulting polymer, with or without purification, can be stored at 4°C. for several months.

Homopolymer of MAA-PEO4-VN can be prepared following the same protocolexcept HEMA monomer is omitted.

Example 3: Preparation of Coating Composition

Coating compositions were prepared by dissolving 2.5 mg ofpoly(HEMA-co-MAA-PEO4-VN) polymer in 10 ml deionized (DI) water. Thesolution can be stored at 4° C. before use.

Example 4: Preparation of Coated Cell Culture Ware

800 μl of coating composition was dispensed in each well of 6 wellplates for ultra-low attachment (ULA) treated, tissue culture treated(TCT) treated and CellBIND® treated polystyrene (PS) plates. In the caseof non-treated polystyrene plates, 2 ml of the coating composition wasdispensed in each well of 6 well plates. The plates were then placedeither into a 37° C. incubator for 6 hours, or into a 80° C. oven for 15min or exposed to 30 J/cm² UV light dose provided by a Fusion “D” bulb.The excess coating composition was then aspirated. The plates werewashed for 1 hour with 1% sodium dodecyl sulfate (SDS) aqueous solutionfollowed by rinsing with DI water and dried with a dry air flow. Theplates were ready for sanitization or sterilization.

T-flask and CellStack™ parts were coated using the same protocol exceptthat 6 ml and 40 ml coating composition were dispensed into each T-flaskand CellStack™ respectively.

Immobilized peptide density was determined by a bicinchoninic acid (BCA)assay using a BCA protein quantification kit from Uptima. Standards wereprepared using VN peptide (KGGPQVTRGDVFTMP, SEQ ID NO:1) in PBS.Absorbance was read on a Biotek® Synergy 4.

Coating homogeneity assessment and quantification of the peptide polymerimmobilized was done by colloidal gold staining using Colloidal GoldTotal Protein Stain reagent available from Bio-Rad Laboratories (catalog170-6527) absorbance was read at 565 nm on a Biotek Synergy 4.

FIG. 5 shows the amount of immobilized copolymer on different substratesmeasured by colloidal gold total protein staining. Tested substratesinclude non-treated polystyrene (PS), TCT-treated, CellBIND®-treated andULA-treated 6 well polystyrene plates. A higher amount of thepoly(HEMA-co-MAA-PEO4-VN) polymer was immobilized on TCT and Cellbind®plates.

FIG. 6 shows the results from the BCA assay. In FIG. 6 absorbance at 562nM, which correlates to the amount of immobilized peptide (pmol/mm²), isshown for non-treated (PS), TCT treated, CellBIND® treated and ULAtreated 6 well polystyrene plates. The quantification reproduces theresults of the colloidal gold assay shown in FIG. 5: a higher amount ofthe poly(HEMA-co-MAA-PEO4-VN) polymer was immobilized on TCT andCellbind® plates.

FIG. 7 shows the amount of immobilized copolymer on TCT substrate usingdifferent methods to immobilize the polymer such as UV light exposure(30 J/cm²), and heating at 80° C. for 15 minutes, 37° C. for 6 hours, orno heating (2 minutes at room temperature). The amount of immobilizedcopolymer was determined by colloidal gold total protein staining. Theresults presented in FIG. 7 show that a higher amount ofpolypeptide-polymer was immobilized on substrates exposed to heat or UVlight, with a much lower amount when the thermal or UV treatment wasomitted.

FIG. 8 shows the amount of immobilized peptide (pmol/mm²) according to aBCA assay for TCT treated 6 well polystyrene plates coated as describedabove and incubated at 37° C. for 6 hours, 80° C. for 15 min or exposedto 30 J/cm² UV-A at 40-50° C., or no treatment (2 minutes at roomtemperature). The results presented in FIG. 8 show that a higher amountof polypeptide-polymer was immobilized on substrates exposed to heat orUV light, with a much lower amount when the thermal or UV treatment wasomitted, and that heating or UV treatment produces similar results.

FIGS. 9A-C are photographs showing colloidal gold staining (ColloidalGold Total Protein Stain reagent available from Bio-Rad, Hercules,Calif.) of a T-75 flask (FIG. 9A), CellStack layer (FIG. 9B) and 6 wellplate (FIG. 9C) coated as described above. FIG. 10 is a photographshowing colloidal gold staining of a 96 well plate coated as describedherein. The photographs of FIGS. 9-10 show that coatings describedherein can be effectively applied to a variety of cell culture ware. Inaddition the photographs illustrate the high homogeneity of coating insmall volume vessels (FIG. 10) and vessels with varying shapes (FIGS.9A-C).

FIG. 11 is a graph showing the quantification of the colloidal goldstaining of the 96 wellplate from FIG. 11. Optical density was measuredat 565 nm. These data confirm the exceptionally good homogeneity of thecoating.

Example 5: Culture of Human Embryonic Stem Cells: BG01v hESC

1×10⁶ BG01v human embryonic stem cells (hESC), Passage 35, were seededin each of three wells of a six well plate and incubated at 37° C. Oneplate contained wells coated as described above, and another plate wascoated with Matrigel™ Coating: BD Matrigel™ Lot # A5628 (BD biosciencecat#356231) in accordance with the manufacturer's instructions. Theplates were sanitized by incubating with ethanol 70% v/v in water beforeseeding. The cells were cultured in a chemically defined medium: mTeSR1®Media (StemCell Technologies cat #05850), 4 ml per well, 1× feed (day2).

Cells were harvested from 2 wells at day 3 and counted. 9.09×10⁶ cellswere collected from the plate coated as described above and 9.59×10⁶cells were collected from the Matrigel™ coated plate. The fold expansionwas 4.54 and 4.79 for the polymer-polypeptide coated surface describedabove and Matrigel™, respectively. In both cases cell harvesting waseasily performed in less than 5 minutes by enzymatic Digestion using0.05% Trypsin-EDTA Solution (Gibco/Invitrogen, cat#25300).

FIG. 12 shows BG01v hESC colonies 3 days after seeding on the Matrigel™coated plate (FIG. 12A) and on the polymer-polypeptide coated plateprepared as described herein (FIG. 12B). The polymer-polypeptide coatedplates were prepared by dispensing 600 μl of 0.25 mg/mlpeptide-copolymer aqueous solution and were sanitized with 70% ethanolfor one hour prior to seeding. Polymer immobilization was performed byexposing the plate to 30 J/cm² UV-A at 40-50° C. The colonies havesimilar morphologies on both the synthetic polymer-polypeptide surfaceand the Matrigel™ biological coating. This experiment illustrates thatsynthetic coatings as described herein can enable hESC culturecomparable to Matrigel™ in chemically defined media and that thesynthetic polymer-polypeptide coatings described herein can surviveethanol sanitization. synthetic polymer-polypeptide coatings describedherein can survive ethanol sanitization.

Example 6: Culture of Bone Marrow-Derived hMSC

70,000 bone marrow-derived human mesenchymal stem cells (hMSC) (StemCellTechnologies cat # MSC-001F), Passage 4, were seeded into each well of asix well plate and incubated at 37° C. One plate contained wells coatedwith a polymer-polypeptide as described above (UV, 30 J/cm²), anotherplate was coated with MesenCult®-XF Attachment Substrate (StemCellTechnologies cat#05424-1:28 dilution in 1× DPBS) in accordance with themanufacturer's instructions, and another plate was coated with Corning'sSynthemax™ synthetic substrate. The cells were cultured in a chemicallydefined medium: MesenCult®-XF Medium (StemCell Technologies cat#05420),3 ml per well, Feed 1× (day 2). Cells were harvested at day 4 byenzymatic digestion with 0.05% trypsin-EDTA solution (Gibco/Invitrogen,cat#25300) and were counted.

FIG. 13 shows that cell viability and fold expansion are comparable tothose achieved with MesenCult® attachment substrate biological coatingand Synthemax™ synthetic coating. This experiment showed that hMSC canbe cultured on the synthetic polymer-polypeptide substrate describedherein in Xeno-free media with acceptable cell viability and cellexpansion. These data also show that viability is comparable to thebiological MesenCult attachment substrate while fold expansion slightlylower but comparable to Synthemax™, which is believed to be the bestsynthetic surface available.

The photomicrographs on FIG. 14 show morphology of bone marrow-derivedhMSC, 2 and 4 days after seeding on the polymer-polypeptide coatingdescribed above (FIG. 14A and FIG. 14B) and MesenCult® attachmentsubstrate biological coating (FIG. 14C and FIG. 14D). On bothsubstrates, cells morphology looks very similar.

Example 7: Culture of Mouse Embryonic Stem Cells

ES-D3 cells (ATCC # CRL-11632) were grown in Dulbecco's Modified EagleMedium, Life Technologies Carlsbad, Calif., medium supplemented with 15%FBS and 0.1 mM beta-mecaptoethanol as recommended per ATCC, Carlsbad,Calif. Cells were trypsinized and diluted before they reach confluence.Then they were counted, washed in D-PBS and resuspended in mTeSR1synthetic medium (Stem Cell Technologies, Vancouver, BC, CA). 7×10⁵cells per well were then seeded as single cells in 6 well plate formatin 2 ml mTeSR1 and incubated at 37° C.

FIGS. 15A-D are photomicrographs of ESD3 mESC colonies formed after 1day from single cell seeding on non-treated polystyrene (FIG. 15D), TCTtreated polystyrene (FIG. 15A), CellBIND® treated polystyrene (FIG. 15B)and ULA treated (FIG. 15C) polystyrene plates coated in accordance withthe teachings presented herein. A greater number of colonies formed onthe TCT and CellBIND® treated polystyrene coated plates than on the ULAand non-treated polystyrene coated plates, which is in good agreementwith the amount of immobilized peptide determined by BCA (FIG. 6).

FIG. 16 shows that single cell seeding leads to nice mESC coloniesformed after 1 day culture and also those synthetic polymer-polypeptidecoatings as described herein and that the coatings survive ethanolsanitization FIG. 16A shows cells that were seeded on coatings that werenot ethanol sterilized. FIG. 16B shows cells that were seeded oncoatings that were ethanol sterilized (1 hour sanitization with 70%ethanol). FIG. 16 shows that colonies look similar on both non-sanitizedand sanitized coating demonstrating that the coating resists ethanolsanitization. Plates were prepared by dispensing 700 μl of 0.25 mg/mlaqueous solution of the peptide-copolymer. Polymer immobilization wasperformed by incubating the plate at 80° C. for 15 min.

Thus, embodiments of SYNTHETIC COATING FOR CELL CULTURE are disclosed.One skilled in the art will appreciate that the coatings, articles,compositions and methods described herein can be practiced withembodiments other than those disclosed. The disclosed embodiments arepresented for purposes of illustration and not limitation.

1-25. (canceled)
 26. An aqueous solution, comprising: a polymerconjugated to a polypeptide formed from polymerization of (i)methacrylic acid conjugated to the polypeptide and (ii)hydroxyethylmethacrylate, 6 wherein the polymer has a linear backbone,wherein the polymer is crosslink free, and wherein the weight percentageof the polypeptide relative to the polymer conjugated to the polypeptideis sufficiently high to render the polymer conjugated to the polypeptidewater soluble at 25° C.
 27. The aqueous solution of claim 26, whereinwere the polymer not conjugated to the polypeptide, the polymer would beinsoluble in water at 37° C.
 28. The aqueous solution of claim 26,wherein the weight percentage of the polypeptide relative to the polymerconjugated to the polypeptide is greater than 40%.
 29. The aqueoussolution of claim 26, wherein the weight percentage of the polypeptiderelative to the polymer conjugated to the polypeptide is greater than60%.
 30. The aqueous solution of claim 26, wherein the polypeptide is acell adhesive polypeptide.
 31. The aqueous solution of claim 26, whereinthe polypeptide comprises an RGD sequence.
 32. The aqueous solution ofclaim 28, wherein the polypeptide comprises an RGD sequence.
 33. Theaqueous solution of claim 29, wherein the polypeptide comprises an RGDsequence.
 34. The aqueous solution of claim 31, wherein the polypeptideis selected from the group of a vitronectin polypeptide, a collagenpolypeptide, a laminin polypeptide, a bone sialoprotein polypeptide, anda fibronectin polypeptide.
 35. The aqueous solution of claim 32, whereinthe polypeptide is selected from the group of a vitronectin polypeptide,a collagen polypeptide, a laminin polypeptide, a bone sialoproteinpolypeptide, and a fibronectin polypeptide.
 36. The aqueous solution ofclaim 33, wherein the polypeptide is selected from the group of avitronectin polypeptide, a collagen polypeptide, a laminin polypeptide,a bone sialoprotein polypeptide, and a fibronectin polypeptide.
 37. Theaqueous solution of claim 34, wherein the polypeptide is a vitronectinpolypeptide.
 38. The aqueous solution of claim 35, wherein thepolypeptide is a vitronectin polypeptide.
 39. The aqueous solution ofclaim 36, wherein the polypeptide is a vitronectin polypeptide.
 40. Theaqueous solution of claim 26, wherein the polymer conjugated to thepolypeptide has a molecular weight of between 10 kilodaltons and 1000kilodaltons.
 41. The aqueous solution of claim 31, wherein the polymerconjugated to the polypeptide has a molecular weight of between 10kilodaltons and 1000 kilodaltons.
 42. The aqueous solution of claim 32,wherein the polymer conjugated to the polypeptide has a molecular weightof between 10 kilodaltons and 1000 kilodaltons.
 43. The aqueous solutionof claim 33, wherein the polymer conjugated to the polypeptide has amolecular weight of between 10 kilodaltons and 1000 kilodaltons.
 44. Theaqueous solution of claim 26, wherein the aqueous solution comprisesbetween 0.1 mg/ml and 0.5 mg/ml of the polymer conjugated to thepolypeptide.
 45. The aqueous solution of claim 31, wherein the aqueoussolution comprises between 0.2 mg/ml and 0.3 mg/ml of the polymerconjugated to the polypeptide.
 46. The aqueous solution of claim 32,wherein the aqueous solution comprises between 0.2 mg/ml and 0.3 mg/mlof the polymer conjugated to the polypeptide.
 47. The aqueous solutionof claim 33, wherein the aqueous solution comprises between 0.2 mg/mland 0.3 mg/ml of the polymer conjugated to the polypeptide.
 48. Acomposition comprising: an aqueous solution; and a polymer conjugated toa polypeptide dissolved in the aqueous solution; wherein the polymer isformed from monomers comprising methacrylic acid conjugated to apolypeptide and hydroxyethylmethacrylate; wherein the polymer iscrosslink free; wherein a substantially similar polymer that is notconjugated to the polypeptide is insoluble in water at 37° C.; and,wherein the weight percentage of the polypeptide relative to the polymerconjugated to the polypeptide is sufficiently high to render the polymerconjugated to the polypeptide water soluble in the aqueous solution at25° C.
 49. A method of forming a coated cell culture article comprisingthe steps of: disposing the aqueous solution of claim 26 onto a surfaceupon which cells can be cultured; exposing the aqueous solution and thesurface to heat or electromagnetic radiation; and, producing a coatedcell culture article having the polymer conjugated to the polypeptideattached to the surface.
 50. A coated cell culture article made by themethod of claim 26.